Stock Track | Seaport Therapeutics Soars 25.72% on IPO Debut Amid Strong Investor Demand

Stock Track
05/02

Seaport Therapeutics' stock soared 25.72% intraday on Friday, marking a strong debut for the biotechnology company.

The surge follows the company's initial public offering, which was priced at $18 per share at the top of the targeted range. The IPO was upsized to 14.2 million shares from 11.8 million shares, reflecting robust investor interest. The offering is expected to generate approximately $254.9 million in gross proceeds for the company.

Seaport Therapeutics' stock began trading on the Nasdaq Global Select Market under the ticker SPTX, with the opening price significantly above the IPO price, driving the substantial intraday gain.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10